News & insights Recent ICG news, insights, research and analysis. Journalist, shareholder or client with an enquiry? Contact us News ICG realises successful investment in Kee Safety 1 July 2025 News ICG Real Estate acquires £136.5m London-centric retail parks portfolio 26 June 2025 News Draig Therapeutics Launches with $140m Investment to Advance Next-Generation Therapies for Major Neuropsychiatric Disorders 18 June 2025 News ICG invests a further £4m to continue flagship educational opportunity and social mobility programme 12 June 2025 Annual reports Delivering a milestone year for ICG 9 June 2025 News View all ICG realises successful investment in Kee Safety 1 July 2025 ICG Real Estate acquires £136.5m London-centric retail parks portfolio 26 June 2025 Draig Therapeutics Launches with $140m Investment to Advance Next-Generation Therapies for Major Neuropsychiatric Disorders 18 June 2025 ICG invests a further £4m to continue flagship educational opportunity and social mobility programme 12 June 2025 Hakim Group partners with ICG to accelerate growth plan 22 May 2025 View all Research & market analysis View all Trade War Views: Implications for the Economic Outlook and Business Operating Environment 16 April 2025 US and Europe Private Company Trends: Bucking the trend 12 February 2025 What does Trump’s election win mean for the global economy? 27 November 2024 The Easing Cycle Begins 12 October 2024 US and Europe Private Company Trends: Resilience Sustained 23 July 2024 View all Insights View all Delivering a milestone year for ICG 9 June 2025 High standards of governance for responsible growth 9 June 2025 Meet ICG at SuperReturn International 2025 15 April 2025 Scaling up and scaling out, enabling employees to reach new heights 10 April 2025 ICG publishes its second Charitable Giving Impact Report 27 March 2025 View all
News Draig Therapeutics Launches with $140m Investment to Advance Next-Generation Therapies for Major Neuropsychiatric Disorders 18 June 2025
News ICG invests a further £4m to continue flagship educational opportunity and social mobility programme 12 June 2025
Draig Therapeutics Launches with $140m Investment to Advance Next-Generation Therapies for Major Neuropsychiatric Disorders 18 June 2025
ICG invests a further £4m to continue flagship educational opportunity and social mobility programme 12 June 2025
Trade War Views: Implications for the Economic Outlook and Business Operating Environment 16 April 2025